Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33)
| קרן | National Institute of Allergy and Infectious Diseases/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 28/07/2020 |
| פקולטה | Engineering, Exact Sciences, Life Sciences, Medicine |
| תיאור | The objective of this grant is to pair Bioengineers and Immunologists to leverage emerging innovative knowledge in physical and computational sciences for the design and development of an HIV-1 vaccine.
Funding: No fixed limit Duration: R61 3 years; R33 2 years
Research Authority due date: 22.6.20 LOI (encouraged) due date: 29.6.20 Full proposal due date: 28.7.20 |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 11/03/2020 |
